After giving artificial intelligence tools to thousands of employees, Bristol Myers Squibb is now working to get a handle on the costs of the technology and where it’s actually creating productivity and financial returns.
PALO ALTO, CA — After giving artificial intelligence tools to thousands of employees, Bristol Myers Squibb is now working to get a handle on the costs …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Big business rush to embrace AI runs into worries of rising costs
AI costs spiral as firms lose spending control - The Economic Times
AI’s big cost problem is only going to get worse
Enterprise AI Adoption Enters a New Phase as Companies Shift Focus From Access to ROI
After the AI binge, companies balk at soaring bills
Australia's CBA flags surging AI costs as tasks grow complex, slams 'work slop' - The Economic Times
Firms spent heavily on AI. Now rising costs are outpacing its value
AI saves time but most companies waste the gain
The Token Trap: Why Your Enterprise Might Lose Financial Control Of Its AI Program
After AI frenzy, companies begin to feel sting of soaring bills
The biopharma company will use the AI model across research, drug development, manufacturing, and commercial and medical affairs
The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have…
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
Bristol Myers Squibb partners with Anthropic to deploy Claude AI across 30,000 employees, embedding agentic AI into drug…
The pharmaceutical giant cut procurement timelines from months to weeks while challenging conventional wisdom on AI data…
Anche Bristol Myers Squibb si affida all'intelligenza artificiale per accelerare la scoperta di nuovi farmaci e sceglie Anthropic
